Skip to content

MPM BioVentures 2018 GP LLC, 10% owner at Entrada Therapeutics, sold TRDA on Sep 9, 2026

Data as of Oct 16

▼ SELL$206K28,837 shares at $7.13MPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Sep 9, 2026
Disclosed
Sep 9, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

MPM BioVentures 2018 GP LLC, 10% owner at Entrada Therapeutics, sold TRDA on Sep 9, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−38.5%
after the sale
Similar stocks (XLV) since disclosure
+6.1%
XLV — its sector index fund

Change in closing price from Sep 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  2. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  3. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  4. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  5. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  7. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  8. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late

See every trade on TRDA →